Inova Health Care Services

Quick facts

Marketed products

• influenza trivalent inactive vaccine
• Initial Heparin Dose Modification
• Namenda · Neuroscience
• Vorapaxar and Aspirin
• Vorapaxar and Clopidogrel · Cardiovascular
  Vorapaxar and clopidogrel work together as dual antiplatelet agents to prevent blood clots by blocking platelet activation and aggregation through different pathways.
• Vorapaxar, Aspirin, and Clopidogrel · Cardiovascular
  This combination therapy inhibits platelet aggregation through multiple pathways: vorapaxar blocks the protease-activated receptor-1 (PAR-1), while aspirin and clopidogrel inhibit different steps in platelet activation and clotting cascade.

Phase 2 pipeline

• Consolidation Doublet Therapy:
• Induction Chemotherapy Triplet Therapy
• Opiate based pain regimen.

Phase 1 pipeline

• arginine in powder form
• Imatinib mesylate and panitumumab

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Inova Health Care Services portfolio CI brief
• Inova Health Care Services pipeline updates RSS